Alcohol and cardiovascular disease: Still unresolved underlying mechanisms

Vascular Pharmacology

Volumn 57, Issue 2-4, 2012, Pages 69-71

  Carnevale, Roberto ^a   Nocella, Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetaldehyde; Adhesion molecules; Atherosclerosis; Ethanol; Oxidative stress

Indexed keywords

ACETALDEHYDE; ALCOHOL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL CONSUMPTION; ATHEROSCLEROTIC PLAQUE; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; EDITORIAL; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETALDEHYDE; ALCOHOL DRINKING; ALCOHOL-INDUCED DISORDERS; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ETHANOL; HUMANS; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; REACTIVE OXYGEN SPECIES;

EID: 84865441687     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.06.005     Document Type: Editorial

References (35)

1. Agarwal D.P., Srivastava L.M. Does moderate alcohol intake protect against coronary heart disease?. Indian Heart J. 2001, 53:224-230.
2. Ajani U.A., Hennekens C.H., Spelsberg A., Manson J.E. Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians. Arch. Intern. Med. 2000, 160:1025-1030.
3. Aroor A.R., Shukla S.D. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004, 74:2339-2364.
4. Camargo C.A., Stampfer M.J., Glynn R.J., Grodstein F., Gaziano J.M., Manson J.E., Buring J.E., Hennekens C.H. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann. Intern. Med. 1997, 126:372-375.
5. Camargo C.A., Stampfer M.J., Glynn R.J., Gaziano J.M., Manson J.E., Goldhaber S.Z., Hennekens C.H. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation 1997, 95:577-580.
6. Cook R.T., Keiner J., Yen A. Ethanol causes accelerated G1 arrest in differentiating HL-60 cells. Alcohol. Clin. Exp. Res. 1990, 14:695-703.
7. Dey A.B., Choudhury D. How frequent and how much alcohol prevents heart attack?. Natl. Med. J. India 1997, 10:284-285.
8. Diehl A.M. Effect of ethanol on tumor necrosis factor signaling during liver regeneration. Clin. Biochem. 1999, 32:571-578.
9. Elkind M.S., Sciacca R., Boden-Albala B., Rundek T., Paik M.C., Sacco R.L. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006, 37:13-19.
10. Frid A. Moderate alcohol drinking protects against heart disease. Lakartidningen 2000, 97:946-947.
11. Fries J.W., Williams A.J., Atkins R.C., Newman W., Lipscomb M.F., Collins T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol. 1993, 143:725-737.
12. Gaziano J.M., Gaziano T.A., Glynn R.J., Sesso H.D., Ajani U.A., Stampfer M.J., Manson J.E., Hennekens C.H., Buring J.E. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J. Am. Coll. Cardiol. 2000, 35:96-105.
13. Gillman M.W., Cook N.R., Evans D.A., Rosner B., Hennekens C.H. Relationship of alcohol intake with blood pressure in young adults. Hypertension 1995, 25:1106-1110.
14. Gresele P., Pignatelli P., Guglielmini G., Carnevale R., Mezzasoma A.M., Ghiselli A., Momi S., Violi F. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J. Nutr. 2008, 138:1602-1608.
15. Guerri C., Montoliu C., Renau-Piqueras J. Involvement of free radical mechanism in the toxic effects of alcohol: implications for fetal alcohol syndrome. Adv. Exp. Med. Biol. 1994, 366:291-305.
16. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals, and disease. J. Biochem. 1984, 219:1-14.
17. Hannuksela M.L., Liisanantti M.K., Savolainen M.J. Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis. Crit. Rev. Clin. Lab. Sci. 2002, 39:225-283.
18. Pai Jennifer K., Hankinson Susan E., Thadhani Ravi, Rifai Nader, Pischon Tobias, Rimma Eric B. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006, 186:113-120.
19. Kishore R., Hill J.R., McMullen M.R., Frenkel J., Nagy L.E. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. 2001, 282:G6-G15.
20. Klatsky A.L., Friedman G.D., Siegelaub A.B. Alcohol and mortality. A ten-year Kaiser-Permanente experience. Ann. Intern. Med. 1981, 95:139-145.
21. Maraldi C., Volpato S., Kritchevsky S.B., Cesari M., Andresen E., Leeuwenburgh C., Harris T.B., Newman A.B., Kanaya A., Johnson K.C., Rodondi N., Pahor M. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study. Arch. Intern. Med. 2006, 166:1490-1497.
22. Maskarinec G., Meng L., Kolonel L.N. Alcohol intake, body weight, and mortality in a multiethnic prospective cohort. Epidemiology 1998, 9:654-661.
23. Pacher P., Szabó C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 2006, 6:136-141.
24. Raitakari O.T., Celermajer D.S. Testing for endothelial dysfunction. Ann. Med. 2000, 32:293-304.
25. Ridker P.M. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994, 28(272):929-933.
26. Rui G., Jun R. Alcohol and acetaldehyde in public health: from marvel to menace. Int. J. Environ. Res. Public Health 2010, 7:1285-1301.
27. Samanek M. Does moderate alcohol drinking decrease the incidence and mortality rate in ischemic heart disease?. Cas. Lek. Cesk. 2000, 139:747-752.
28. Shirpoor A., Salami S., Khadem-Ansari M.H., Heshmatian B., Ilkhanizadeh B. Long-term ethanol consumption initiates atherosclerosis in rat aorta through inflammatory stress and endothelial dysfunction. Vascul. Pharmacol. 2012, (PMID: 22521742).
29. Taddei S., Ghiadoni L., Virdis A., Versari D., Salvetti A. Mechanisms of endothelial dysfunction: clinical significance and preventative non-pharmacological therapeutic strategies. Curr. Pharm. Des. 2003, 9:2385-2402.
30. Thadhani R., Camargo C.A., Stampfer M.J., Curhan G.C., Willett W.C., Rimm E.B. Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch. Intern. Med. 2002, 162:569-574.
31. Thorand B., Baumert J., Doring A., Schneider A., Chambless L., Lowel H., Kolb H., Koenig W. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study. Thromb. Haemost. 2006, 95:134-141.
32. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2005.
33. Vallance P., Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001, 85:342-350.
34. Xin-sheng D., Deitrich R.A. Ethanol metabolism and effects: nitric oxide and its interaction. Curr. Clin. Pharmacol. 2007, 2:145-153.
35. Zhang X., Li S.H., Brown R.A., Ren J. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol 2004, 32:175-186.